Metal Ions as Activators of Hypoxia Inducible Factor
- Autores: Osipyants A.I.1, Smirnova N.A.1, Khristichenko A.Y.1, Nikulin S.V.1, Zakhariants A.A.2, Tishkov V.I.3,2, Gazaryan I.G.1,3, Poloznikov A.A.1
-
Afiliações:
- Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
- Innovations and High Technologies MSU Ltd.
- Faculty of Chemistry
- Edição: Volume 73, Nº 1 (2018)
- Páginas: 13-18
- Seção: Article
- URL: https://journal-vniispk.ru/0027-1314/article/view/163588
- DOI: https://doi.org/10.3103/S0027131418020128
- ID: 163588
Citar
Resumo
Activation of antihypoxic program under the action of a number of transition and heavy metals has been studied using cell-based HIF1 ODD-luc and HRE-luc reporters. It has been demonstrated that Au3+, Pb2+, Sn2+, Hg2+ are weak HIF1 ODD-luc activators, likely reflecting their weak competition for the ironbinding site in the active center of HIF prolyl hydroxylase. Metals capable of replacing iron–Mn2+, Zn2+, Cu2+ и Ni2+–activate at high submillimolar concentrations, which indicates low permeability of the cell membrane for transition metals. The highest activation is observed for Co2+ and Cd2+, however, Cd2+ is highly toxic even at 10 μM, in contrast to Co2+, which activates both reporters without toxicity signs up to 25 μM for 24 h. A significant activation by Co2+ is observed already in low micromolar range of concentrations, which can be recommended for use in hypoxia mimicking.
Palavras-chave
Sobre autores
A. Osipyants
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Autor responsável pela correspondência
Email: osssip@gmail.com
Rússia, Moscow, 117997
N. Smirnova
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Rússia, Moscow, 117997
A. Khristichenko
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Rússia, Moscow, 117997
S. Nikulin
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Rússia, Moscow, 117997
A. Zakhariants
Innovations and High Technologies MSU Ltd.
Email: osssip@gmail.com
Rússia, Moscow, 109451
V. Tishkov
Faculty of Chemistry; Innovations and High Technologies MSU Ltd.
Email: osssip@gmail.com
Rússia, Moscow, 119991; Moscow, 109451
I. Gazaryan
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia; Faculty of Chemistry
Email: osssip@gmail.com
Rússia, Moscow, 117997; Moscow, 119991
A. Poloznikov
Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
Email: osssip@gmail.com
Rússia, Moscow, 117997
Arquivos suplementares
